The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis.

The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis. Abstract Text:

Ira Tabas,Tracie Seimon,Jerry Arellano,Yankun Li,Fabien Forcheron,Dongying Cui,Seongah Han,Chien-Ping Liang,Alan Tall,Domenico Accili,

The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis. Publishing Authors By Initials

I Tabas,T Seimon,J Arellano,Y Li,F Forcheron,D Cui,S Han,CP Liang,A Tall,D Accili,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Novartis Foundation symposium

VOLUME: 286

Page Numbers: 99-109; discussion 109-12, 162

Journal Abbreviation:

ISSN: 1528-2511

DAY: 13

MONTH: 02

YEAR: 2007

The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9807767

The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis.

AFFILIATION:

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Novartis Found Symp

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis Related Publications

• A Foxo/Notch pathway controls myogenic differentiation and fiber type specification.
• Analysis of compensatory beta-cell response in mice with combined mutations of Insr and Irs2.
• Clinical review 125: The insulin receptor and its cellular targets.
• Evolutionary analyses of KCNQ1 and HERG voltage-gated potassium channel sequences reveal location-specific susceptibility and augmented chemical severities of arrhythmogenic mutations.
• Hyperpolarization-activated cyclic nucleotide-modulated 'HCN' channels confer regular and faster rhythmicity to beating mouse embryonic stem cells.
• Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor foxo1 in liver.
• Insulin receptor knock-out mice.
• Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes.
• Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1.
• New insights into the integrated physiology of insulin action.
• Regulation of cell surface expression of functional pacemaker channels by a motif in the B-helix of the cyclic nucleotide-binding domain.
• Regulation of pancreatic beta-cell function by the forkhead protein FoxO1.
• SirT1 gain of function increases energy efficiency and prevents diabetes in mice.
• The double life of irs.
• The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression.
• The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis.